GÜR, S. Et Al. 2013. Update on Drug Interactions With Phosphodiesterase-5 Inhibitors Prescribed as First-Line Therapy for Patients with Erectile Dysfunction or Pulmonary Hypertension. CURRENT DRUG METABOLISM , vol.14, no.2 , 265-269.

GÜR, S., Kadowitz, P. J., Gokce, A., Sikka, S. C., Lokman, U., & Hellstrom, W. J. G., (2013). Update on Drug Interactions With Phosphodiesterase-5 Inhibitors Prescribed as First-Line Therapy for Patients with Erectile Dysfunction or Pulmonary Hypertension. CURRENT DRUG METABOLISM , vol.14, no.2, 265-269.

GÜR, SERAP Et Al. "Update on Drug Interactions With Phosphodiesterase-5 Inhibitors Prescribed as First-Line Therapy for Patients with Erectile Dysfunction or Pulmonary Hypertension," CURRENT DRUG METABOLISM , vol.14, no.2, 265-269, 2013

GÜR, SERAP Et Al. "Update on Drug Interactions With Phosphodiesterase-5 Inhibitors Prescribed as First-Line Therapy for Patients with Erectile Dysfunction or Pulmonary Hypertension." CURRENT DRUG METABOLISM , vol.14, no.2, pp.265-269, 2013

GÜR, S. Et Al. (2013) . "Update on Drug Interactions With Phosphodiesterase-5 Inhibitors Prescribed as First-Line Therapy for Patients with Erectile Dysfunction or Pulmonary Hypertension." CURRENT DRUG METABOLISM , vol.14, no.2, pp.265-269.

@article{article, author={SERAP GÜR Et Al. }, title={Update on Drug Interactions With Phosphodiesterase-5 Inhibitors Prescribed as First-Line Therapy for Patients with Erectile Dysfunction or Pulmonary Hypertension}, journal={CURRENT DRUG METABOLISM}, year=2013, pages={265-269} }